Adoption and decision factors regarding selective treatment of clinical mastitis on Canadian dairy farms

E de Jong, KD Mccubbin, T Uyama, Carmen Brummelhuis, J Bodaneze, DF Kelton, S Dufour, J Sanchez, JP Roy, LC Heider, D Rizzo, D Leger, HW Barkema*

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Abstract

As clinical mastitis (CM) treatments are responsible for a large portion of antimicrobial use on dairy farms, many selective CM treatment protocols have been developed and evaluated against a blanket treatment approach of CM cases. Selective treatment protocols use outcomes of diagnostic tests to exclude CM cases from antimicrobial treatment when they are unlikely to benefit. To tailor interventions to increase uptake of selective treatment strategies, a comprehension of current on-farm treatment practices and factors affecting treatment decisions is vital. Two questionnaires were conducted among 142 farms across 5 provinces participating in the Canadian Dairy Network for Antimicrobial Stewardship and Resistance in this cross-sectional study. Self-reported adoption of selective CM treatments by dairy farmers was 64%, with median of 82% of cows treated in those herds using selective treatment. Using logistic regression models, the odds to implement a selective CM treatment protocol increased with a decreasing average cow somatic cell count. No other associations were identified between use of a selective CM treatment protocol and farm characteristics (herd size, CM incidence, province, milking system, and housing system). Three subsets of farmers making cow-level CM treatment decisions were identified using a cluster analysis approach: those who based decisions almost exclusively on severity of clinical signs, those who used various udder health indicators, and farmers who also incorporated more general cow information such as production, age, and genetics. When somatic cell count was considered, the median threshold used for treating was >300,000 cells/mL at the last Dairy Herd Improvement test. Various thresholds were present among those considering CM case history. Veterinary laboratories were most frequently used for bacteriological testing. Test results were used to start, change, and stop treatments. Regardless of protocol, reasons for antimicrobial treatment withheld included cow being on a cull list, having a chronic intramammary infection, or being at end of lactation (i.e., close to dry off). If clinical signs persisted after treatment, farmers indicated that they would ask veterinarians for advice, stop treatment, or continue with the same or different antibiotics. Results of this study can be used to design interventions targeting judicious mastitis-related antimicrobial use, and aid discussions between veterinarians and dairy producers regarding CM-related antimicrobial use.
Original languageEnglish
Pages (from-to)476-488
Number of pages13
JournalJournal of Dairy Science
Volume107
Issue number1
DOIs
Publication statusPublished - Jan 2024

Keywords

  • antimicrobial stewardship
  • antimicrobial use
  • bovine mastitis
  • decision making
  • protocol

Fingerprint

Dive into the research topics of 'Adoption and decision factors regarding selective treatment of clinical mastitis on Canadian dairy farms'. Together they form a unique fingerprint.

Cite this